Indicator summary: Leaning bullish (3 bullish, 1 bearish, 1 neutral). As of 2026-10-13, the close was $271.18: 18.0% above the 50-day average and 61.8% above the 200-day average, which is rising. RSI (14) is 59, in its neutral range. MACD is bearish after a cross in the last 10 days. The stock sits 83% of the way up its 52-week range of $88.00 to $309.35, on 0.4x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $229.81 | Price 18.0% above |
| 200-day average | $167.65 | Price 61.8% above, average rising |
| 50 vs 200-day | 50 above 200 | Golden-cross alignment |
| RSI (14) | 59 | Neutral range |
| MACD (12, 26, 9) | +13.81 vs +15.22 | Bearish cross in the last 10 days |
| 52-week range | $88.00 to $309.35 | 83% of the way up the range |
| Volume vs 20-day average | 0.4x | Light |
Base rates use ILMN's own daily history since 2000; they describe the past, not a forecast.
As of 2026-10-13, ILMN's 14-day RSI is 59, which is in the neutral range between 30 and 70.
Yes. ILMN closed at $271.18 on 2026-10-13, 61.8% above its 200-day average of $167.65, which is rising. When it closed above its 200-day average (3,930 days), it was higher 63 trading days later 63% of the time, median +7.5%.
Yes. ILMN closed at $271.18 on 2026-10-13, 18.0% above its 50-day average of $229.81. When it closed above its 50-day average (3,745 days), it was higher 63 trading days later 60% of the time, median +5.7%.
Yes, a bearish cross within the last 10 trading days. As of 2026-10-13 the MACD line is +13.81 against a signal line of +15.22, so MACD is bearish.
No. At $271.18 it sits 83% of the way up its 52-week range of $88.00 to $309.35, 12.3% below the high.
Leaning bullish: 3 of 5 indicators are bullish and 1 bearish as of 2026-10-13 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Bearish, from the chart signal model.
ILMN analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.